These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New targets for non-small-cell lung cancer therapy. Alvarez M; Roman E; Santos ES; Raez LE Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567 [TBL] [Abstract][Full Text] [Related]
7. [Responses to targeted therapies: lung cancer]. Brambilla E Ann Pathol; 2009 Nov; 29 Spec No 1():S77-80. PubMed ID: 19887261 [No Abstract] [Full Text] [Related]
8. Cancer stem cells: a step toward the cure. Boman BM; Wicha MS J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956 [No Abstract] [Full Text] [Related]
9. [The biological features and their roles of cancer stem cells in invasion and neovascularization of cancer]. Bian XW Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):505-6. PubMed ID: 20021957 [No Abstract] [Full Text] [Related]
10. Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma. Ria R; Vacca A; Ribatti D; Di Raimondo F; Merchionne F; Dammacco F Haematologica; 2002 Aug; 87(8):836-45. PubMed ID: 12161360 [TBL] [Abstract][Full Text] [Related]
12. Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention? Yeudall WA; Miyazaki H Expert Rev Anticancer Ther; 2007 Mar; 7(3):351-60. PubMed ID: 17338654 [TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of cancer testis antigen genes in glioma stem cells. Yawata T; Nakai E; Park KC; Chihara T; Kumazawa A; Toyonaga S; Masahira T; Nakabayashi H; Kaji T; Shimizu K Mol Carcinog; 2010 Jun; 49(6):532-44. PubMed ID: 20082319 [TBL] [Abstract][Full Text] [Related]
14. [Cancer initiating cell theory: popularity and controversies]. Chen H; Huang Q; Dong J; Lan Q Ai Zheng; 2006 Jun; 25(6):779-84. PubMed ID: 16764781 [TBL] [Abstract][Full Text] [Related]
15. Overview of novel anticancer drug targets. Buolamwini JK; Assefa H Methods Mol Med; 2003; 85():3-28. PubMed ID: 12710193 [No Abstract] [Full Text] [Related]
16. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; CalabrĂ² L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]
17. Brain tumor stem cells: bringing order to the chaos of brain cancer. Dirks PB J Clin Oncol; 2008 Jun; 26(17):2916-24. PubMed ID: 18539973 [TBL] [Abstract][Full Text] [Related]
18. Current status and issues in cancer stem cell study. Yang YM; Chang JW Cancer Invest; 2008 Aug; 26(7):741-55. PubMed ID: 18608212 [TBL] [Abstract][Full Text] [Related]
20. Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment. Caers J; Van Valckenborgh E; Menu E; Van Camp B; Vanderkerken K Bull Cancer; 2008 Mar; 95(3):301-13. PubMed ID: 18390410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]